Evidence map›Paper›PMID 29609538›Full record

ArticleBMC cancer2018

Significance of CD133 positive cells in four novel HPV-16 positive cervical cancer-derived cell lines and biopsies of invasive cervical cancer.

Shifa Javed, Bal Krishan Sharma, Swati Sood, Sanjeev Sharma, Rashmi Bagga, Shalmoli Bhattacharyya, Charan Singh Rayat, Lakhbir Dhaliwal, Radhika Srinivasan

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. SF1, a Standardised Fraction fromThe Malaysian journal of medical sciences : MJMS · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Chloroform extract ofMolecular medicine reports · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shifa JavedMolecular Pathology Laboratory, Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, PIN-160012, India.
Bal Krishan SharmaMolecular Pathology Laboratory, Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, PIN-160012, India.
Swati SoodMolecular Pathology Laboratory, Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, PIN-160012, India.
Sanjeev SharmaMolecular Pathology Laboratory, Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, PIN-160012, India.
Rashmi BaggaDepartment of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Shalmoli BhattacharyyaDepartment of Biophysics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Charan Singh RayatDepartment of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lakhbir DhaliwalDepartment of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Radhika SrinivasanMolecular Pathology Laboratory, Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, PIN-160012, India. drsradhika@gmail.com.ORCID 0000-0002-1771-091X
Post Graduate Institute of Medical Education and Research · IN

Funding

Indian Council for Medical research ICMR-JRF-2012/HRD-139(10056)SERB, Department of Science and Technology, Ministry of Science and Technology, Govt. of India DST No: D.O. No.-SR/SO/HS-0166/2010
6 · The paper itself

Abstract

backgroundCervical cancer is a major cause of cancer-related mortality in women in the developing world. Cancer Stem cells (CSC) have been implicated in treatment resistance and metastases development; hence understanding their significance is important.

methodsPrimary culture from tissue biopsies of invasive cervical cancer and serial passaging was performed for establishing cell lines. Variable Number Tandem Repeat (VNTR) assay was performed for comparison of cell lines with their parental tissue. Tumorsphere and Aldefluor assays enabled isolation of cancer stem cells (CSC); immunofluorescence and flow cytometry were performed for their surface phenotypic expression in cell lines and in 28 tissue samples. Quantitative real-time PCR for stemness and epithelial-mesenchymal transition (EMT) markers, MTT cytotoxicity assay, cell cycle analysis and cell kinetic studies were performed.

resultsFour low-passage novel cell lines designated RSBS-9, - 14 and - 23 from squamous cell carcinoma and RSBS-43 from adenocarcinoma of the uterine cervix were established. All were HPV16+. VNTR assay confirmed their uniqueness and derivation from respective parental tissue. CSC isolated from these cell lines showed CD133

conclusionLow-passage cell lines developed would serve as models for studying tumor biology. Cancer Stem Cells in cervical cancer display CD133

Indexed as

AC133 AntigenAntineoplastic AgentsBiopsyCell CycleCell Line, TumorCell Self RenewalCisplatinEpithelial-Mesenchymal TransitionFemaleFlow CytometryHuman papillomavirus 16HumansKaryotypeMinisatellite RepeatsNeoplastic Stem CellsPapillomavirus InfectionsAC133 AntigenAntineoplastic AgentsCisplatinCancer stem cellsCD133Cell linesCervical cancerHPV16Low passage

Identifiers

PMID29609538
PMCPMC5879557
OpenAlexW2804308367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.